Results 251 to 260 of about 181,664 (310)

Daratumumab, bortezomib and dexamethasone for previously treated myeloma—Real‐world outcomes for 2545 patients treated in England

open access: yes
British Journal of Haematology, EarlyView.
Sarah L. Lawton   +4 more
wiley   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective Treatment. [PDF]

open access: yesCancers (Basel)
Shubina IZ   +11 more
europepmc   +1 more source

Monitoring of haematopoietic stem cell mobilization by targeted DNA methylation analysis for the British Journal of Haematology

open access: yes
British Journal of Haematology, EarlyView.
Wouter H. G. Hubens   +3 more
wiley   +1 more source

Autologe Chondrozyten Transplantation

open access: yes, 2003
Shakibaei, M   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy